Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 12, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 37
- −2 vs. Q1 2026
- Portfolio value
- $92.0M
- −$17.9M (−16.3%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Vanguard Ftse Emerging Markets ETF922042858 | ETF | 180,376 | $10.8M | 11.7% | +214+0.1% | Added | – |
| iShares Tr46435G516 | ESG AW MSCI EAFE | 104,247 | $10.7M | 11.6% | −150,180−59.0% | Reduced | – |
| iShares Inc46434G863 | ESG AWR MSCI EM | 192,398 | $10.5M | 11.4% | −177,055−47.9% | Reduced | – |
| iShares Core High Dividend ETF46429B663 | ETF | 342,756 | $9.39M | 10.2% | +2,321+0.7% | AddedConverted for a 5-for-1 split | – |
| iShares MSCI USA Momentum Factor ETF46432F396 | ETF | 24,434 | $8.38M | 9.1% | +200+0.8% | Added | – |
| Nushares ETF Tr67092P300 | NUVEEN ESG LRGVL | 140,912 | $7.04M | 7.7% | −54,745−28.0% | Reduced | – |
| DBX ETF Tr233051200 | XTRACK MSCI EAFE | 126,734 | $6.92M | 7.5% | −158−0.1% | Reduced | – |
| Flexshares Tr33939L688 | STOX GLB INDEX | 21,669 | $5.05M | 5.5% | −22,570−51.0% | Reduced | – |
| NVDANVIDIA Corp | Stock | 19,532 | $3.91M | 4.2% | +5,291+37.2% | Added | History |
| Vanguard Ftse Developed Markets ETF921943858 | ETF | 47,559 | $3.39M | 3.7% | +252+0.5% | Added | – |
| iShares Core S&P 500 ETF464287200 | ETF | 4,450 | $3.33M | 3.6% | −24−0.5% | Reduced | – |
| iShares Inc46434G509 | CUR HD MSCI EM | 58,203 | $2.60M | 2.8% | −337−0.6% | Reduced | – |
| JPMJPMorgan Chase & Co | Stock | 4,997 | $1.64M | 1.8% | +13+0.3% | Added | History |
| DEDeere & Co | Stock | 1,172 | $743.2K | 0.8% | +36+3.2% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 1,409 | $585.8K | 0.6% | −574−28.9% | Reduced | History |
| INCYIncyte Corp | COM | 5,091 | $577.1K | 0.6% | +858+20.3% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 6,158 | $557.1K | 0.6% | −416−6.3% | Reduced | History |
| ProShares Tr74347R107 | PSHS ULT S&P 500 | 8,180 | $551.2K | 0.6% | +16+0.2% | Added | – |
| ProShares Tr74347R842 | PSHS ULTRUSS2000 | 7,997 | $537.7K | 0.6% | +7+0.1% | Added | – |
| ABTAbbott Laboratories | Stock | 5,665 | $514.1K | 0.6% | +622+12.3% | Added | History |
| WisdomTree Tr97717W562 | US SMALLCAP FUND | 7,020 | $475.9K | 0.5% | −1,212−14.7% | Reduced | – |
| PFEPfizer Inc | Stock | 18,210 | $438.5K | 0.5% | +5,120+39.1% | Added | History |
| MDTMedtronic plc | Stock | 5,319 | $416.1K | 0.5% | 00.0% | Unchanged | History |
| DHRDanaher Corp | Stock | 2,040 | $388.5K | 0.4% | +752+58.4% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 669 | $335.6K | 0.4% | +90+15.5% | Added | History |
| OTFBlue Owl Technology Finance Corp. | COMMON STOCK | 29,654 | $306.9K | 0.3% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 10,568 | $305.2K | 0.3% | −5,091−32.5% | Reduced | History |
| PMPhilip Morris International Inc. | Stock | 1,463 | $264.6K | 0.3% | +13+0.9% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 415 | $258.8K | 0.3% | −45−9.8% | Reduced | History |
| Schwab US Dividend Equity ETF808524797 | ETF | 7,676 | $243.4K | 0.3% | −7,443−49.2% | Reduced | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 1,084 | $236.3K | 0.3% | −233−17.7% | Reduced | – |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 26,968 | $159.1K | 0.2% | +12,067+81.0% | Added | History |
| GERNGeron Corp | COM | 88,779 | $113.6K | 0.1% | +33,654+61.1% | Added | History |
| CTMXCytomX Therapeutics, Inc. | COM | 25,033 | $93.9K | 0.1% | +12,557+100.6% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 21,822 | $92.5K | 0.1% | +7,428+51.6% | Added | History |
| NKTXNkarta, Inc. | COM | 28,955 | $81.9K | 0.1% | −14,880−33.9% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 14,240 | $81.3K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (2)
Positions held at the end of Q1 2026 that are gone from this filing.